0000950123-22-005030.txt : 20220510 0000950123-22-005030.hdr.sgml : 20220510 20220510162523 ACCESSION NUMBER: 0000950123-22-005030 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220510 DATE AS OF CHANGE: 20220510 EFFECTIVENESS DATE: 20220510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 22910098 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001560009 XXXXXXXX 03-31-2022 03-31-2022 false Versant Venture Management, LLC

One Sansome Street, Suite 3630 San Francisco CA 94104

13F HOLDINGS REPORT 028-16849 N Robin L. Praeger (415) 801-8100 /s/ Robin L. Praeger San Francisco CA 05-10-2022 0 10 100171 false INFORMATION TABLE 2 13154.xml INFORMATION TABLE FOR FORM 13F Adverum Biotechnologies, Inc. Common Stock 00773U108 6639 5068233 SH OTR 0 5068233 0 Akero Therapeutics, Inc. Common Stock 00973Y108 8766 617727 SH OTR 0 617727 0 Aligos Therapeutics, Inc. Common Stock 01626L105 4989 2320381 SH OTR 0 2320381 0 Clovis Oncology, Inc. Common Stock 189464100 206 101855 SH OTR 0 101855 0 Crinetics Pharmaceuticals, Inc. Common Stock 22663K107 9007 410360 SH OTR 0 410360 0 CRISPR Therapeutics AG Common Shares H17182108 31294 498558 SH OTR 0 498558 0 CymaBay Therapeutics, Inc. Common Stock 23257D103 1691 543753 SH OTR 0 543753 0 Gritstone Oncology, Inc. Common Stock 39868T105 14672 3561150 SH OTR 0 3561150 0 Minerva Surgical Inc. Common Stock 60343F106 7532 1673700 SH OTR 0 1673700 0 Passage Bio, Inc. Common Stock 702712100 15375 4959769 SH OTR 0 4959769 0